Transcriptome analysis of human brain tissue identifies reduced expression of complement complex C1Q Genes in Rett syndrome

[1]  Uday Kishore,et al.  Emerging and Novel Functions of Complement Protein C1q , 2015, Front. Immunol..

[2]  Michael J. Yetman,et al.  Wild-type microglia do not reverse pathology in mouse models of Rett syndrome , 2015, Nature.

[3]  Steffen Jung,et al.  Methyl-CpG Binding Protein 2 Regulates Microglia and Macrophage Gene Expression in Response to Inflammatory Stimuli. , 2015, Immunity.

[4]  Harrison W. Gabel,et al.  Disruption of DNA methylation-dependent long gene repression in Rett syndrome , 2015, Nature.

[5]  Matthew E. Ritchie,et al.  limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.

[6]  L. Pozzo-Miller,et al.  Dendritic spine dysgenesis in Rett syndrome , 2014, Front. Neuroanat..

[7]  S. Dudoit,et al.  Normalization of RNA-seq data using factor analysis of control genes or samples , 2014, Nature Biotechnology.

[8]  David P. Kreil,et al.  The concordance between RNA-seq and microarray data depends on chemical treatment and transcript abundance , 2014, Nature Biotechnology.

[9]  Björn Usadel,et al.  Trimmomatic: a flexible trimmer for Illumina sequence data , 2014, Bioinform..

[10]  G. Ananiev,et al.  Mutant astrocytes differentiated from Rett syndrome patients-specific iPSCs have adverse effects on wild-type neurons. , 2014, Human molecular genetics.

[11]  Wei Shi,et al.  featureCounts: an efficient general purpose program for assigning sequence reads to genomic features , 2013, Bioinform..

[12]  Beth Stevens,et al.  TGF-β Signaling Regulates Neuronal C1q Expression and Developmental Synaptic Refinement , 2013, Nature Neuroscience.

[13]  Renaud Gaujoux,et al.  CellMix: a comprehensive toolbox for gene expression deconvolution , 2013, Bioinform..

[14]  Johann A. Gagnon-Bartsch,et al.  Using control genes to correct for unwanted variation in microarray data. , 2012, Biostatistics.

[15]  Chris Williams,et al.  RNA-SeQC: RNA-seq metrics for quality control and process optimization , 2012, Bioinform..

[16]  James C. Cronk,et al.  Wild type microglia arrest pathology in a mouse model of Rett syndrome , 2012, Nature.

[17]  J. Leek,et al.  Temporal dynamics and genetic control of transcription in the human prefrontal cortex , 2011, Nature.

[18]  R. Veerhuis,et al.  Complement in the brain. , 2011, Molecular immunology.

[19]  J. Raber,et al.  A role for glia in the progression of Rett’s syndrome , 2011, Nature.

[20]  Rodney C. Samaco,et al.  Complexities of Rett Syndrome and MeCP2 , 2011, The Journal of Neuroscience.

[21]  Xiangqin Cui,et al.  Design and validation issues in RNA-seq experiments , 2011, Briefings Bioinform..

[22]  Robert S. Illingworth,et al.  Neuronal MeCP2 is expressed at near histone-octamer levels and globally alters the chromatin state. , 2010, Molecular cell.

[23]  Mark D. Robinson,et al.  edgeR: a Bioconductor package for differential expression analysis of digital gene expression data , 2009, Bioinform..

[24]  J. Christodoulou,et al.  Downstream targets of methyl CpG binding protein 2 and their abnormal expression in the frontal cortex of the human Rett syndrome brain , 2010, BMC Neuroscience.

[25]  Matthew D. Young,et al.  Gene ontology analysis for RNA-seq: accounting for selection bias , 2010, Genome Biology.

[26]  Christina Thaller,et al.  Mouse models of MeCP2 disorders share gene expression changes in the cerebellum and hypothalamus , 2009, Human molecular genetics.

[27]  Lior Pachter,et al.  Sequence Analysis , 2020, Definitions.

[28]  Pan Du,et al.  lumi: a pipeline for processing Illumina microarray , 2008, Bioinform..

[29]  Stephen T. C. Wong,et al.  MeCP2, a Key Contributor to Neurological Disease, Activates and Represses Transcription , 2008, Science.

[30]  Y. Xing,et al.  A Transcriptome Database for Astrocytes, Neurons, and Oligodendrocytes: A New Resource for Understanding Brain Development and Function , 2008, The Journal of Neuroscience.

[31]  Jonathan Pevsner,et al.  FXYD1 is an MeCP2 target gene overexpressed in the brains of Rett syndrome patients and Mecp2-null mice. , 2007, Human molecular genetics.

[32]  K. Shiota,et al.  Methyl-CpG-binding Protein, MeCP2, Is a Target Molecule for Maintenance DNA Methyltransferase, Dnmt1* , 2003, The Journal of Biological Chemistry.

[33]  Eric P. Hoffman,et al.  Gene Expression Profiling in Postmortem Rett Syndrome Brain: Differential Gene Expression and Patient Classification , 2001, Neurobiology of Disease.

[34]  H. Zoghbi,et al.  Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2 , 1999, Nature Genetics.

[35]  Colin A. Johnson,et al.  Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex , 1998, Nature.